Leiomyosarcoma - Pipeline Review, H2 2018

www.MarketResearchReports.com
Category : Drug Pipeline
All logos and Images mentioned on this slide belong to their respective owners.

Introduction to Report
 Launch Date: August 14, 2018
 Number of Pages: 330
 Geography Coverage: Global
 Available Format: PDF
Price For Single User License: USD 2,000
Price For Site User License: USD 4,000
Price For Global User License: USD 6,000
Delivery Time: Within 24 Hours (During Working
Days)

About the Report
Leiomyosarcoma - Pipeline Review, H2 2018,
provides an overview of the Leiomyosarcoma
(Oncology) pipeline landscape.
Leiomyosarcoma is an aggressive soft tissue
sarcoma derived from smooth muscle cells
typically of uterine, gastrointestinal or soft tissue
origin.

Report Highlights;
This report provides comprehensive information on the
therapeutics under development for Leiomyosarcoma
(Oncology), complete with analysis by stage of
development, drug target, mechanism of action (MoA),
route of administration (RoA) and molecule type.
The guide covers the descriptive pharmacological action
of the therapeutics, its complete research and
development history and latest news and press releases.
The Leiomyosarcoma (Oncology) pipeline guide also
reviews of key players involved in therapeutic
development for Leiomyosarcoma and features dormant
and discontinued projects.
The guide covers therapeutics under Development by
Companies /Universities /Institutes, the molecules
developed by Companies in Pre-Registration, Phase II,
Phase I and Preclinical stages are 1, 10, 6 and 2
respectively.

Report Highlights; Continues..
Similarly, the Universities portfolio in Phase II stages
comprises 1 molecules, respectively.
Leiomyosarcoma (Oncology) pipeline guide helps in
identifying and tracking emerging players in the market
and their portfolios, enhances decision making
capabilities and helps to create effective counter
strategies to gain competitive advantage.
The guide is built using data and information sourced
from Publisher’s proprietary databases,
company/university websites, clinical trial registries,
conferences, SEC filings, investor presentations and
featured press releases from company/university sites
and industry-specific third party sources.
Additionally, various dynamic tracking processes ensure
that the most recent developments are captured on a
real time basis.

Scope:
The pipeline guide provides a snapshot of the global
therapeutic landscape of Leiomyosarcoma (Oncology).
The pipeline guide reviews pipeline therapeutics for
Leiomyosarcoma (Oncology) by companies and
universities/research institutes based on information
derived from company and industry-specific sources.
The pipeline guide covers pipeline products based on
several stages of development ranging from pre-
registration till discovery and undisclosed stages.
The pipeline guide features descriptive drug profiles for
the pipeline products which comprise, product
description, descriptive licensing and collaboration
details, R&D brief, MoA & other developmental activities.
The pipeline guide reviews key companies involved in
Leiomyosarcoma (Oncology) therapeutics and enlists all
their major and minor projects.

Scope: Continues…
The pipeline guide evaluates Leiomyosarcoma
(Oncology) therapeutics based on mechanism of action
(MoA), drug target, route of administration (RoA) and
molecule type.
The pipeline guide encapsulates all the dormant and
discontinued pipeline projects.
The pipeline guide reviews latest news related to
pipeline therapeutics for Leiomyosarcoma (Oncology)

Reasons to buy:
Procure strategically important competitor information,
analysis, and insights to formulate effective R&D
strategies.
Recognize emerging players with potentially strong
product portfolio and create effective counter-strategies
to gain competitive advantage.
Find and recognize significant and varied types of
therapeutics under development for Leiomyosarcoma
(Oncology).
Classify potential new clients or partners in the target
demographic.
Develop tactical initiatives by understanding the focus
areas of leading companies.
Plan mergers and acquisitions meritoriously by
identifying key players and it’s most promising pipeline
therapeutics.

Reasons to buy: Continues…
Formulate corrective measures for pipeline projects by
understanding Leiomyosarcoma (Oncology) pipeline
depth and focus of Indication therapeutics.
Develop and design in-licensing and out-licensing
strategies by identifying prospective partners with the
most attractive projects to enhance and expand
business potential and scope.
Adjust the therapeutic portfolio by recognizing
discontinued projects and understand from the know-
how what drove them from pipeline.

Report Coverage:
1. Introduction
2. Leiomyosarcoma - Overview
3. Leiomyosarcoma - Therapeutics Development
4. Leiomyosarcoma - Therapeutics Assessment
5. Leiomyosarcoma - Companies Involved in
Therapeutics Development
6. Leiomyosarcoma - Drug Profiles
7. Leiomyosarcoma - Dormant Projects
8. Appendix
For more details regarding Report coverage see the last slide

Company Coverage: (Partial List)
1. Advenchen Laboratories LLC
2. BeiGene Ltd
3. Cell Medica Ltd
4. Eli Lilly and Co
5. F. Hoffmann-La Roche Ltd
6. Karyopharm Therapeutics Inc
7. Merck & Co Inc
8. Merck KGaA
9. Millennium Pharmaceuticals Inc
10. Mirati Therapeutics Inc
11. Nektar Therapeutics
For more details regarding Report coverage see the last slide

Custom Research:
 Are you an industry professional, entrepreneur,
venture capitalist, investors and organization, then let
us know your specific research requirements. Our goal
is to cater to your requirements be it for a custom
market research project, syndicated research report on
a specific market or industry sector, newsletter creation,
case study development or anything else related to
marketing research.
For Any Customization Related query Visit IdeaCenter @
http://www.marketresearchreports.com/idea-center
For regular industry updates subscribe to our newsletter
at:
http://www.marketresearchreports.com/subscribe-to-
newsletter

How To Buy This Report?
Visit following URL to see Table of Content and
purchase this publication:
http://mrr.cm/wwz
About MarketResearchReprots.com
Market Research Reports provides a customized set of
reports from reputed Publishers, built on the intelligence
available within organizations and leverages on our
motto of “Intelligence Redefined”.
Contact : Mr. Sudeep Chakravarty
Email : info@marketresearchreports.com
Phone: +1-302-703-9904 (USA) +91-8762746600 (India)

Leiomyosarcoma - Pipeline Review, H2 2018

Recommended

Recommended

More Related Content

More from Market Research Reports, Inc.

More from Market Research Reports, Inc. (20)

Recently uploaded

Recently uploaded (20)

Leiomyosarcoma - Pipeline Review, H2 2018